Alzheimer’s disease is defined as an advanced neurological
disorder that increasingly deprives patients of their memory and ability to
carry out daily activities. As it grows in a human brain, individuals are
likely to practice difficulties in linguistic, agility and insight along with
negative changes in the character and performance such as depression, anxiety,
delusion, hallucination and agitation. Alzheimer's disease is the main source
of dementia all over the world and can be either a major or a mild
neurocognitive disorder. Alzheimer’s is likely to grow exponentially with
increase in ageing population thus, providing a significant market opportunity
in the coming years.
Complete Report
Available at http://www.marketreportsonline.com/429709.html.
The current market for Alzheimer’s disease drugs is limited
as only few drugs have been approved thus, defining a healthy scope of
introduction of new drugs in the market in the coming years. The healthcare
costs associated with Alzheimer’s are also anticipated to rise considerably
since only limited treatment options are available in the market. The Alzheimer
market expects introduction of innovative small molecules, biopharmaceuticals
and disease modifying agents that would help transform the pattern of
Alzheimer’s disease.
Increasing ageing population, growing population of women,
rising life expectancy, increasing healthcare expenditure, improving economic
conditions, and increasing global spending on medicines are some of the major
factors contributing to the growth of Alzheimer’s disease market. However, the
growth of the market is hindered by certain challenges including lack of
availability of effective treatment options, problems in detection and
diagnosis, and insufficient research funding.
Table of Contents
1 Overview
1.1 Definition of Dementia
1.1.1 Causes of Dementia
1.1.2 Types of Dementia
1.2 Definition of Alzheimer
1.2.1 Brain Changes Related to Alzheimer
1.2.2 Risks Associated with Alzheimer
1.2.3 Symptoms of Alzheimer
1.2.4 Diagnosis of Alzheimer
1.2.5 Stages of Alzheimer
1.2.6 Treatment Options for Alzheimer’s disease
1.2.7 Currently Available Drugs for Alzheimer Disease
1.1 Definition of Dementia
1.1.1 Causes of Dementia
1.1.2 Types of Dementia
1.2 Definition of Alzheimer
1.2.1 Brain Changes Related to Alzheimer
1.2.2 Risks Associated with Alzheimer
1.2.3 Symptoms of Alzheimer
1.2.4 Diagnosis of Alzheimer
1.2.5 Stages of Alzheimer
1.2.6 Treatment Options for Alzheimer’s disease
1.2.7 Currently Available Drugs for Alzheimer Disease
2. Market Analysis
2.1 Global Dementia Market
Global Dementia Population
Population by Region & Income
Dementia Expenditure Growth
2.2 Global Alzheimer Market
Market Value
Market Share by Drug Classes
2.1 Global Dementia Market
Global Dementia Population
Population by Region & Income
Dementia Expenditure Growth
2.2 Global Alzheimer Market
Market Value
Market Share by Drug Classes
3. Regional Markets
3.1 The U.S.
Alzheimer Prevalence
Prevalence by Stage & Age Group
Alzheimer Cost by Channel
Death Rate
Market Opportunity for New Drugs
3.2 Asia-Pacific
Dementia Population by Countries
Dementia Expenditure by Countries
3.3 Europe
Alzheimer Prevalence
3.3.1 The UK
Dementia Prevalence
Prevalence by Type
Dementia Cost Breakup
3.1 The U.S.
Alzheimer Prevalence
Prevalence by Stage & Age Group
Alzheimer Cost by Channel
Death Rate
Market Opportunity for New Drugs
3.2 Asia-Pacific
Dementia Population by Countries
Dementia Expenditure by Countries
3.3 Europe
Alzheimer Prevalence
3.3.1 The UK
Dementia Prevalence
Prevalence by Type
Dementia Cost Breakup
4. Market Dynamics
4.1 Growth Drivers
4.1.1 Growing Ageing Population
4.1.2 Increasing Population of Women
4.1.3 Rising Life Expectancy
4.1.4 Rising Healthcare Expenditure
4.1.5 Improving Economic Conditions
4.1.6 Increasing Global Spending on Medicines
4.2 Key Trends and Developments
4.2.1 Pipeline Drugs under Development
4.2.2 Alzheimer as a Major Cause of Deaths in the U.S.
4.2.3 Development of 5-HT6 Antagonists
4.2.4 Higher Lifetime Risk for Women
4.3 Challenges
4.3.1 Lack of Effective Treatment Options
4.3.2 Insufficient Research Funding
4.3.3 Difficulty in Detection and Diagnosis
4.1 Growth Drivers
4.1.1 Growing Ageing Population
4.1.2 Increasing Population of Women
4.1.3 Rising Life Expectancy
4.1.4 Rising Healthcare Expenditure
4.1.5 Improving Economic Conditions
4.1.6 Increasing Global Spending on Medicines
4.2 Key Trends and Developments
4.2.1 Pipeline Drugs under Development
4.2.2 Alzheimer as a Major Cause of Deaths in the U.S.
4.2.3 Development of 5-HT6 Antagonists
4.2.4 Higher Lifetime Risk for Women
4.3 Challenges
4.3.1 Lack of Effective Treatment Options
4.3.2 Insufficient Research Funding
4.3.3 Difficulty in Detection and Diagnosis
5. Competitive Landscape
6. Company Profiles
Purchase a copy of alzheimer
market research report at USD 800 (Single User License) http://www.marketreportsonline.com/contacts/purchase.php?name=429709.
The report, “Global Alzheimer Market” analyzes the currently
prevailing condition of the market along with its future scope of development.
The global alzheimer market along with specific markets of the U.S., Europe
(including the UK) and Asia-Pacific are being discussed in the report. The
major trends, growth drivers as well as issues being faced by the industry are
being presented in this report. The major players in the alzheimer market are
being profiled, along with their key financials and strategies for growth.
Browse All Pharmaceuticals,
Market Research Reports at http://www.marketreportsonline.com/cat/pharmaceuticals-market-research.html.
Other Related Reports
on Pharmaceuticals Market:
Global Diabetes Market Report: 2015 Edition: Diabetes mellitus, or simply
diabetes, is a chronic disease that occurs when the pancreas is no longer able
to make insulin, or when the body cannot make good use of the insulin it
produces. Insulin is a hormone made by the pancreas that acts like a key to let
glucose from the food we eat pass from the blood stream into the cells in the
body to produce energy. All carbohydrate foods are broken down into glucose in
the blood. Insulin helps glucose get into the cells. Type 1 diabetes, Type 2
diabetes and Gestational diabetes are the three types of diabetes.
Global Osteoporosis Market, Patients,
Companies & Forecast: Osteoporosis
is a silent disease until it is complicated by fractures that occur following
minimal trauma or, in some cases, with no trauma. Globally Osteoporosis is
expected to be more than US$ 40 Billion market by 2019. China and India
together have close to 80% of osteoporosis patients worldwide. Whereas this in
case of hip fracture cases both the countries China and India have more than
60% patients. But when we study Osteoporosis in market terms then United States
controls the highest market share followed by China and Japan. Amgen and Eli
Lilly are two dominant players in Osteoporosis drugs market.
No comments:
Post a Comment